The Business Advantages of Developer–Supplier Co-Creation

One of the greatest challenges in the medical device industry is that every new development must simultaneously meet engineering, manufacturing, regulatory, and economic expectations—all within a time-pressured and highly competitive market. In this environment, it is no longer enough to “just” design something well. It must also be manufacturable, reproducible in series, cost-effective, and—last but not least—regulatory compliant.

At Mediagnost, we have believed for over 20 years that the greatest value we can provide our partners comes not only from manufacturing, but from co-thinking—from the very moment an idea is born.

1. Shorter Time-to-Market – because time is a competitive advantage

Decisions made early in the product development process significantly influence the entire lifecycle of the project. When suppliers are involved from the concept phase, it enables:

• Shorter development cycles by reducing redesign and manufacturing roadblocks

• Faster prototyping and initial validation rounds

• Earlier market launch of a ready-to-sell product—an essential advantage in a fast-paced industry

At Mediagnost, speed never compromises quality. It is the result of intentional design-for-manufacturing and proactive collaboration.

2. Cost Efficiency – the final price is determined by early design decisions

A common mistake in development is ignoring real-world manufacturing constraints during the design phase—leading to costly redesigns or manufacturing compromises.

We prevent this by:

• Advising on material selection: choosing the most suitable option for function, lifecycle, and production feasibility

• Applying DFM (Design for Manufacturing) and DFA (Design for Assembly) principles to reduce complexity and streamline production

• Avoiding unnecessary scrap, rework, and inefficiencies from the outset

Thoughtful manufacturability is one of the most powerful cost-saving factors in the long run.

3. Regulatory Compliance from the First Step

Under MDR (EU 2017/745) and ISO 13485:2016, not only the final product manufacturer but also the supplier is held accountable. That’s why it’s critical for suppliers to understand:

• Documentation requirements (DHF, DHR, DMR, traceability)

• Regulatory and validation expectations (IQ, OQ, PQ)

• Risk management and change control processes

Our workflows at Mediagnost are fully auditable and designed to support development teams right from the prototype phase.

Co-Creation – Not Just a Slogan, but a Working Principle

Our engineers work closely with the partners’ R&D teams in:

• Functional prototyping

• Custom testing and measuring equipment

• Development of control electronics sub-systems

This collaborative model helps turn ideas into functional, high-quality, market-ready products—on the most efficient path possible.

Long-Term Development Partner, Not Just a Supplier

At Mediagnost, we are not just subcontractors—we act as strategic partners in joint development efforts, alongside global leaders like Siemens Healthineers, Philips DXR, and Mediso.

We believe that every successful medical innovation is backed by a strong and integrated engineering–supplier collaboration.